Top-ranked by US News & World Report
College of Medicine Fact Sheet


Whitney Hendrickson Women's Cancer Facility

 

   
Clinical Services
 UK GYN Oncology
  About Us (GYN Oncology)
  Patient Care (GYN Onc)
  Faculty & Physician Faces
  Appointments & Directions  
  FAQs   
   
  Information Resources
  Fellowship Information
  Clinical Trials at UK 
   
UK Ovarian Cancer Screening
News & Events: UK College of Medicine Calendar
     
   
   
Open UK Clinical Trials
UK Clinical Trials
   
UK GYN ONCOLOGY

Fellowship Information 

Fellow Research Citations
March
2014
. 

Mark Reedy, M.D.

  1. Dietrich CS 3rd, Modesitt SC, DePriest PD, Ueland FR, Wilder J, Reedy MB, Pavlik EJ, Kryscio R, Cibull M, Giesler J, Manahan K, Huh W, Cohn D, Powell M, Slomovitz B, Higgins RV, Merritt W, Hunter J, Puls L, Gehrig P, van Nagell JR Jr.  The efficacy of adjuvant platinum-based chemotherapy in Stage I uterine papillary serous carcinoma (UPSC). Gynecol Oncol. 2005 Dec;99(3):557-63. Epub 2005 Sep 8. PMID: 16154185 [PubMed - indexed for MEDLINE]
  2. Reedy MB, Hang T, Gallion H, Arnold S, Smith SA.  Antisense inhibition of BRCA1 expression and molecular analysis of hereditary tumors indicate that functional inactivation of the p53 DNA damage response pathway is required for BRCA-associated tumorigenesis.  Gynecol Oncol. 2001 Jun;81(3):441-6.
    PMID: 11371136 [PubMed - indexed for MEDLINE]
  3. Cardosi RJ, Reedy MB, Van Nagell JR, Spires SE.  Neuroendocrine signet ring cell adenocarcinoma of the endocervix.  Int J Gynecol Cancer. 1999 Sep;9(5):433-437.  PMID: 11240807 [PubMed - as supplied by publisher]
  4. Pavlik EJ, DePriest PD, Gallion HH, Ueland FR, Reedy MB, Kryscio RJ, van Nagell JR Jr.  Ovarian volume related to age.  Gynecol Oncol. 2000 Jun;77(3):410-2.  PMID: 10831351 [PubMed - indexed for MEDLINE]
  5. van Nagell JR Jr, DePriest PD, Reedy MB, Gallion HH, Ueland FR, Pavlik EJ, Kryscio RJ.  The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer.  Gynecol Oncol. 2000 Jun;77(3):350-6.  PMID: 10831341 [PubMed - indexed for MEDLINE]
  6. Reedy MB, Richards WE, Ueland F, Uy K, Lee EY, Bryant C, van Nagell JR Jr.  Ovarian steroid cell tumors, not otherwise specified: a case report and literature review. Gynecol Oncol. 1999 Nov;75(2):293-7. Review.

James Wilder, M.D.

  1. Wilder JL, Shajahan S, Khattar NH, Wilder DM, Yin J, Rushing RS, Beaven R, Kaetzel C, Ueland FR, van Nagell JR, Kryscio RJ, Lele SM.  Tamoxifen-associated malignant endometrial tumors: pathologic features and expression of hormone receptors estrogen-alpha, estrogen-beta and progesterone; a case controlled study.  Gynecol Oncol. 2004 Feb;92(2):553-8.
    PMID: 14766247 [PubMed - indexed for MEDLINE]
  2. Rushing RS, Shajahan S, Chendil D, Wilder JL, Pulliam J, Lee EY, Ueland FR, van Nagell JR, Ahmed MM, Lele SM.  Uterine sarcomas express KIT protein but lack mutation(s) in exon 11 or 17 of c-KIT. Gynecol Oncol. 2003 Oct;91(1):9-14.  PMID: 14529657 [PubMed - indexed for MEDLINE]
  3. Wilder JL, Pavlik E, Straughn JM, Kirby T, Higgins RV, DePriest PD, Ueland FR, Kryscio RJ, Whitley RJ, Nagell J.  Clinical implications of a rising serum CA-125 within the normal range in patients with epithelial ovarian cancer: a preliminary investigation.  Gynecol Oncol. 2003 May;89(2):233-5. PMID: 12713985 [PubMed - indexed for MEDLINE]
  4. Dietrich III C, Modesitt S, DePriest P, Ueland F, Wilder J, Reedy M, Kryscio R, van Nagell Jr JR, Giesler J, Manahan K, Huh W, Cohn D, Powell M, Slomovitz B, Higgins R, Merritt W, Hunter J, Puls L, Gehrig P:  The Efficacy of Adjuvant Platinum-based Chemotherapy in Stage I Uterine Papillary Serous Carcinoma (UPSC).  Gynecol. Oncol. 99:557-563, 2005.

 Jeanne Schilder, M.D.

  1. Dietrich CS 3rd, DeSimone CP, Modesitt SC, DePriest PD, Ueland FR, Pavlik EJ, Kryscio R, Cibull M, Huh W, Partridge E, Numnum TM, Schilder J, Higgins RV, van Nagell JR Jr.  Primary appendiceal cancer: Gynecologic manifestations and treatment options.  Gynecol Oncol. 2007 Mar;104(3):602-6. Epub 2006 Oct 20. PMID: 17055559 [PubMed - in process]
  2. Schilder JM, Thompson AM, DePriest PD, Ueland FR, Cibull ML, Kryscio RJ, Modesitt SC, Lu KH, Geisler JP, Higgins RV, Magtibay PM, Cohn DE, Powell MA, Chu C, Stehman FB, van Nagell J.  Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy.  Gynecol Oncol. 2002 Oct;87(1):1-7. PMID: 12468335 [PubMed - indexed for MEDLINE]

 Scott Rushing, M.D.

  1. Wilder JL, Shajahan S, Khattar NH, Wilder DM, Yin J, Rushing RS, Beaven R, Kaetzel C, Ueland FR, van Nagell JR, Kryscio RJ, Lele SM.  Tamoxifen-associated malignant endometrial tumors: pathologic features and expression of hormone receptors estrogen-alpha, estrogen-beta and progesterone; a case controlled study.  Gynecol Oncol. 2004 Feb;92(2):553-8.
    PMID: 14766247 [PubMed - indexed for MEDLINE]
  2. Rushing RS, Shajahan S, Chendil D, Wilder JL, Pulliam J, Lee EY, Ueland FR, van Nagell JR, Ahmed MM, Lele SM.  Uterine sarcomas express KIT protein but lack mutation(s) in exon 11 or 17 of c-KIT.  Gynecol Oncol. 2003 Oct;91(1):9-14.  PMID: 14529657 [PubMed - indexed for MEDLINE]

 Nick Chobanian, M.D.

  1. Chobanian NH, Greenberg VL, Gass JM, Desimone CP, Van Nagell JR, Zimmer SG.  Histone deacetylase inhibitors enhance paclitaxel-induced cell death in ovarian cancer cell lines independent of p53 status.  Anticancer Res. 2004 Mar-Apr;24(2B):539-45.   PMID: 15160991 [PubMed - indexed for MEDLINE]

 Chris DeSimone. M.D.

  1. Dietrich CS 3rd, DeSimone CP, Modesitt SC, Depriest PD, Ueland FR, Pavlik EJ, Kryscio R, Cibull M, Huh W, Partridge E, Numnum TM, Schilder J, Higgins RV, van Nagell JR Jr.  Primary appendiceal cancer: Gynecologic manifestations and treatment options. Gynecol Oncol. 2007 Mar;104(3):602-6. Epub 2006 Oct 20.  PMID: 17055559 [PubMed - in process]
  2. DeSimone CP, Van Ness JS, Cooper AL, Modesitt SC, DePriest PD, Ueland FR, Pavlik EJ, Kryscio RJ, van Nagell JR Jr.  The treatment of lateral T1 and T2 squamous cell carcinomas of the vulva confined to the labium majus or minus. Gynecol Oncol. 2007 Feb;104(2):390-5. Epub 2006 Oct 5. PMID: 17027067 [PubMed - in process]
  3. DeSimone CP, Crisp MP, Ueland FR, DePriest PD, van Nagell JR, Lele SM, Modesitt SC.  Concordance of gross surgical and final fixed margins in vulvar intraepithelial neoplasia 3 and vulvar cancer. J Reprod Med. 2006 Aug;51(8):617-20.  PMID: 16967630 [PubMed - in process]
  4. DeSimone CP, Day ME, Tovar MM, Dietrich CS 3rd, Eastham ML, Modesitt SC.  Rate of pathology from atypical glandular cell Pap tests classified by the Bethesda 2001 nomenclature. Obstet Gynecol. 2006 Jun;107(6):1285-91.  PMID: 16738153 [PubMed - indexed for MEDLINE]
  5. Ueland FR, Depriest PD, DeSimone CP, Pavlik EJ, Lele SM, Kryscio RJ, van Nagell JR Jr.  The accuracy of examination under anesthesia and transvaginal sonography in evaluating ovarian size. Gynecol Oncol. 2005 Nov;99(2):400-3. Epub 2005 Aug 9.  PMID: 16084576 [PubMed - indexed for MEDLINE]
  6. Chobanian NH, Greenberg VL, Gass JM, DeSimone CP, Van Nagell JR, Zimmer SG.  Histone deacetylase inhibitors enhance paclitaxel-induced cell death in ovarian cancer cell lines independent of p53 status. Anticancer Res. 2004 Mar-Apr;24(2B):539-45.  PMID: 15160991 [PubMed - indexed for MEDLINE]
  7. DeSimone, CP, Subodh, LM, Modesitt, SC.  Malignant stuma ovarii: a case report and analysis of cases reported In the literature with focus on survival and I131 therapy.  Gynecologic Oncology 89 2003 89: 543-548.
  8. DePriest PD and DeSimone, CP.  Ultrasound screening for the early detection of ovarian cancer.  J. Clinical Oncology 2003  21: 194s-199s.

 Charles Dietrich III, M.D.

  1. Dietrich CS 3rd, Desimone CP, Modesitt SC, Depriest PD, Ueland FR, Pavlik EJ, Kryscio R, Cibull M, Huh W, Partridge E, Numnum TM, Schilder J, Higgins RV, van Nagell JR Jr.  Primary appendiceal cancer: Gynecologic manifestations and treatment options. Gynecol Oncol. 2007 Mar;104(3):602-6. [PubMed Link] | [Full Text] 
  2. DeSimone CP, Day ME, Tovar MM, Dietrich CS 3rd, Eastham ML, Modesitt SC.  Rate of pathology from atypical glandular cell Pap tests classified by the Bethesda 2001 nomenclature.  Obstet Gynecol. 2006 Jun;107(6):1285-91.  PMID: 16738153 [PubMed - indexed for MEDLINE]
  3. Dietrich CS 3rd, Modesitt SC, DePriest PD, Ueland FR, Wilder J, Reedy MB, Pavlik EJ, Kryscio R, Cibull M, Giesler J, Manahan K, Huh W, Cohn D, Powell M, Slivovitz B, Higgins RV, Merritt W, Hunter J, Puls L, Gehrig P, van Nagell JR Jr.  The efficacy of adjuvant platinum-based chemotherapy in Stage I uterine papillary serous carcinoma (UPSC). Gynecol Oncol. 2005 Dec;99(3):557-63. .[PubMed Link] | [Full Text] 
  4. Dietrich CS 3rd, Greenberg VL, DeSimone CP, Modesitt SC, van Nagell JR, Craven R, Zimmer SG. Suberoylanilide hydroxamic acid (SAHA) potentiates paclitaxel-induced apoptosis in ovarian cancer cell lines.  Gynecol Oncol. 2010 Jan;116(1):126-30. [PubMed Link] | [Full Text]  

 Amy Cooper, M.D.

  1. Huh WK, Straughn JM Jr, Mariani A, Podratz KC, Havrilesky LJ, Alvarez-Secord A, Gold MA, McMeekin DS, Modesitt S, Cooper AL, Powell MA, Mutch DG, Nag S, Alvarez RD, Cohn DE.  Salvage of isolated vaginal recurrences in women with surgical stage I endometrial cancer: a multiinstitutional experience. Int J Gynecol Cancer. 2007 Feb 14; [Epub ahead of print]
    PMID: 17309665 [PubMed - as supplied by publisher
  2. Cooper AL, Greenberg VL, Lancaster PS, van Nagell JR Jr, Zimmer SG, Modesitt SC.  In vitro and in vivo histone deacetylase inhibitor therapy with suberoylanilide hydroxamic acid (SAHA) and paclitaxel in ovarian cancer.  Gynecol Oncol. 2007 Mar;104(3):596-601. Epub 2006 Oct 16.
    PMID: 17049973
    [PubMed Link] | [Full Text]
  3. DeSimone CP, Van Ness JS, Cooper AL, Modesitt SC, DePriest PD, Ueland FR, Pavlik EJ, Kryscio RJ, van Nagell JR Jr.  The treatment of lateral T1 and T2 squamous cell carcinomas of the vulva confined to the labium majus or minus.  Gynecol Oncol. 2007 Feb;104(2):390-5. Epub 2006 Oct 5. PMID: 17027067 [PubMed Link] | [Full Text]  
  4. van Nagell JR Jr, DePriest PD, Ueland FR, DeSimone CP, Cooper AL, McDonald JM, Pavlik EJ, Kryscio RJ. Ovarian cancer screening with annual transvaginal sonography: findings of 25,000 women screened. Cancer. 2007 May 1;109(9):1887-96.PMID: 17373668 [PubMed Link] | [Full Text] 
  5. Cooper AL, Dornfeld-Finke JM, Banks HW, Davey DD, Modesitt SC.  Is cytologic screening an effective surveillance method for detection of vaginal recurrence of uterine cancer?  Obstet Gynecol. 2006 Jan;107(1):71-6.  PMID: 16394042 [PubMed - indexed for MEDLINE]  
  6. Cooper, AL, Nelson, DF, Doran, S, Ueland, FR, DeSimone, CP, DePriest, PD , McDonald, JM, Saunders, BA , Ware, RA , Pavlik, EJ ,  Kryscio, RJ, Karpf, M  and  van Nagell, JR. Long-Term Survival and Cost of Treatment in Patients with Stage IIIC Epithelial Ovarian Cancer. Current Women’s Health Reviews, 2009, 5, 44-50

 J. Matt McDonald, M.D.

  1. McDonald, JM, Modesitt, SC The incidental postmenopausal adnexal mass.  Clin. Obstetrics & Gynecology 49 2006: 506-516.
  2. van Nagell JR Jr, DePriest PD, Ueland FR, DeSimone CP, Cooper AL, McDonald JM, Pavlik EJ, Kryscio RJ. Ovarian cancer screening with annual transvaginal sonography: findings of 25,000 women screened. Cancer. 2007 May 1;109(9):1887-96.PMID: 17373668 [PubMed Link] | [Full Text] 
  3. McDonald, JM, Cooper, AL, Modesitt, SC.  Endometrial carcinoma: does selective lymphadenectomy offer a survival advantage.  Society of Gynecological Oncology 2006, Abstract #169.  
  4. Cooper, AL, Nelson, DF, Doran, S, Ueland, FR, DeSimone, CP, DePriest, PD , McDonald, JM, Saunders, BA , Ware, RA , Pavlik, EJ ,  Kryscio, RJ, Karpf, M  and  van Nagell, JR. Long-Term Survival and Cost of Treatment in Patients with Stage IIIC Epithelial Ovarian Cancer. Current Women’s Health Reviews, 2009, 5, 44-50.
  5. McDonald JM, Doran S, DeSimone CP, Ueland FR, DePriest PD, Ware RA, Saunders BA, Pavlik EJ, Goodrich S, Kryscio RJ, van Nagell JR Jr. Predicting risk of malignancy in adnexal masses. Obstet Gynecol. 2010 Apr;115(4):687-94.PMID: 20308826 [PubMed Link] | [Full Text] .
  6. McDonald, J.M.;Karabakhtsian, R.G.;Pierce, H.H.;Iocono, J.A.;Desimone, C.P.;Bayliff, S.L.;Ueland, F.R."Small cell carcinoma of the ovary of hypercalcemic type: a case report." Journal of pediatric surgery47, 3 (2012): 588-92. [PubMed Link] | [Full Text] 

Brook Saunders, M.D.

  1. Cooper, AL, Nelson, DF, Doran, S, Ueland, FR, DeSimone, CP, DePriest, PD , McDonald, JM, Saunders, BA , Ware, RA , Pavlik, EJ ,  Kryscio, RJ, Karpf, M  and  van Nagell, JR. Long-Term Survival and Cost of Treatment in Patients with Stage IIIC Epithelial Ovarian Cancer. Current Women’s Health Reviews, 2009, 5, 44-50

  2. Pavlik EJ, Saunders BA, Doran S, McHugh KW, Ueland FR, DeSimone CP, DePriest PD, Ware RA, Kryscio RJ, van Nagell JR Jr. The search for meaning-Symptoms and transvaginal sonography screening for ovarian cancer: predicting malignancy. Cancer. 2009 Aug 15; 115(16): 3689-98. PMID: 19603478 [PubMed - indexed for MEDLINE]
  3. McDonald JM, Doran S, DeSimone CP, Ueland FR, DePriest PD, Ware RA, Saunders BA, Pavlik EJ, Goodrich S, Kryscio RJ, van Nagell JR Jr. Predicting risk of malignancy in adnexal masses. Obstet Gynecol. 2010 Apr;115(4):687-94.PMID: 20308826 [PubMed Link] | [Full Text] .
  4. Saunders, B, Podzielinski, I, Ware, R, , Goodrich, S, DeSimone, C, Ueland, F, ,DePriest, P, Pavlik, E, Seamon, L, Van Nagell, J. Risk of malignancy in sonographically confirmed septated cystic ovarian tumors.  Society of Gynecologic Oncology 2010 Abstract #53.  
  5. Saunders, B.A.; Podzielinski, I. ;Ware, R.A.; Goodrich, S.T.;Desimone, C.P.;Ueland, F.R.;Seamon, L.;Ubellacker, J.;Pavlik, E.J.;Kryscio, R.J.;Nagell JR, J. "Risk of malignancy in sonographically confirmed septated cystic ovarian tumors." Gynecologic oncology 118, 3 (2010): 278-82. [PubMed Link] | [Full Text] 
  6. Podzielinski, I. ; Saunders, B.A.;Kimbler, K.D.;Branscum, A.J.;Fung, E.T.;DePriest, P.D.;Van Nagell, J.R.;Ueland, F.R.;Baron, A.T. "Apolipoprotein concentrations are elevated in malignant ovarian cyst fluids suggesting that lipoprotein metabolism is dysregulated in epithelial ovarian cancer." Cancer investigation 31, 4 (2013): 258-72. [PubMed Link] | [Full Text] 
  7. Skaggs, H.S.;Saunders, B.A.; Miller, R.W.; Goodrich, S.T.;King, M.S.;Kimbler, K.D.;Branscum, A.J.;Fung, E.T.;DePriest, P.D.;Van Nagell, J.R.;Ueland, F.R.;Baron, A.T. "Ovarian cyst fluids are a cache of tumor biomarkers that include calgranulin A and calgranulin B isoforms." Cancer investigation 31, 7 (2013):433-53. [PubMed Link] | [Full Text] 

Rachel Ware Miller, M.D

  1. Cooper, AL, Nelson, DF, Doran, S, Ueland, FR, DeSimone, CP, DePriest, PD , McDonald, JM, Saunders, BA , Ware, RA , Pavlik, EJ ,  Kryscio, RJ, Karpf, M  and  van Nagell, JR. Long-Term Survival and Cost of Treatment in Patients with Stage IIIC Epithelial Ovarian Cancer. Current Women’s Health Reviews, 2009, 5, 44-50
  2. Pavlik EJ, Saunders BA, Doran S, McHugh KW, Ueland FR, DeSimone CP, DePriest PD, Ware RA, Kryscio RJ, van Nagell JR Jr. The search for meaning-Symptoms and transvaginal sonography screening for ovarian cancer: predicting malignancy. Cancer. 2009 Aug 15; 115(16): 3689-98. PMID: 19603478 [PubMed - indexed for MEDLINE].
  3. McDonald JM, Doran S, DeSimone CP, Ueland FR, DePriest PD, Ware RA, Saunders BA, Pavlik EJ, Goodrich S, Kryscio RJ, van Nagell JR Jr. Predicting risk of malignancy in adnexal masses. Obstet Gynecol. 2010 Apr;115(4):687-94.PMID: 20308826 [PubMed - in process].
  4. Ware, R., Smith, A., DeSimone, C, Seamon, L., Goodrich, S., Podzielinski, I. , Van Nagel!, J., Zhang, Z., Ueland, F.  A  multi-institutional evaluation of ACOG and SGO referral guidelines for an ovarian massSociety of Gynecologic Oncology 2010 Abstract #27.
  5. Saunders, B, Podzielinski, I, Ware, R, , Goodrich, S, DeSimone, C, Ueland, F, ,DePriest, P, Pavlik, E, Seamon, L, Van Nagell, J. Risk of malignancy in sonographically confirmed septated cystic ovarian tumors.  Society of Gynecologic Oncology 2010 Abstract #53.
  6. Ueland, F, DeSimone, C, Seamon, L, Ware, R, Goodrich, S, Podzielinski, I, Smith, A, Santoso, J,. Van Nagell, J, Zhang, Z. The OVA1 test improves the preoperative assessment of ovarian tumors . Society of Gynecologic Oncology 2010 Abstract #54.
  7. DeSimone, C, Ware, R, Seamon, L, Van Nagell, J, Ueland, F. Endometrial cancer recurrence and survival in women with morbid obesity compared with obese and normal/overweight women. , Society of Gynecologic Oncology 2010 Abstract #162.
  8. Ware, R, Pavlik, Doran, S, Darag, W, Reynolds, S,. Ueland, F, DeSimone, C, Podzielinski, I, Van Nagell, J. Prevalence, size and duration of ovarian abnormalities detected on transvaginal sonography Society of Gynecologic Oncology 2010 Abstract #266.  
  9. Radical hysterectomy with pelvic lymphadenectomy: indications, technique, and complications.  

    Ware RA, van Nagell JR.Obstet Gynecol Int. 2010;2010. pii: 587610. Epub 2010 Sep 1.[PubMed Link] |[Full Text] 

    10. Ware Miller, R.;Smith, A.;Desimone, C.P.;Seamon, L.; Goodrich, S.T.; Podzielinski, I.;Sokoll, L.;Nagell JR, J.;Zhang, Z.;Ueland, F.R. "Performance of the American College of Obstetricians and Gynecologists' ovarian tumor referral guidelines with a multivariate index assay." Obstetrics and gynecology 117, 6(2011): 1298-306. [PubMed Link] | [Full Text] 

     

    11. Saunders, B.A.; Podzielinski, I. ;Ware, R.A.; Goodrich, S.T.;Desimone, C.P.;Ueland, F.R.;Seamon, L.;Ubellacker, J.;Pavlik, E.J.;Kryscio, R.J.;Nagell JR, J. "Risk of malignancy in sonographically confirmed septated cystic ovarian tumors." Gynecologic oncology 118, 3 (2010): 278-82. [PubMed Link] | [Full Text] 

     

    12. McDonald, J.M.;D oran , S.;Desimone, C.P.;Ueland, F.R.;DePriest, P.D.; Ware, R.A.; Saunders, B.A.;Pavlik, E.J.; Goodrich, S.T.;Kryscio, R.J.;Nagell JR, J. "Predicting risk of malignancy in adnexal masses." Obstetrics and gynecology 115, 4 (2010): 687-94. [PubMed Link] | [Full Text] 

     

    13. Pavlik, E.J.; Saunders, B.A.;D oran , S.;McHugh, K.W.;Ueland, F.R.;Desimone, C.P.;DePriest, P.D.; Ware, R.A.;Kryscio, R.J.;Nagell JR, J. "The search for meaning-Symptoms and transvaginal sonography screening for ovarian cancer: predicting malignancy." Cancer 115, 16 (2009): 3689-98. [PubMed Link] |[Full Text] 

     

    14. Ware, R.A.;Van Nagell, J.R. "Radical hysterectomy with pelvic lymphadenectomy: indications, technique, and complications." Obstetrics and gynecology international 2010, (2014): [PubMed Link] |[Full Text] 

     

    15. Goodrich, S.T.;Bristow, R.E.;Santoso, J.T.;Miller, R.W.;Smith, A.;Zhang, Z.;Ueland, F.R. "The Effect of Ovarian Imaging on the Clinical Interpretation of a Multivariate Index Assay." American journal of obstetrics and gynecology (2014): [PubMed Link] | [Full Text] 

     

    16. Pavlik, E.J.;Ueland, F.R.; Miller, R.W.;Ubellacker, J.M.;Desimone, C.P.; Elder, J.; Hoff, J.; Baldwin, L.;Kryscio, R.J.;Nagell JR, J. "Frequency and disposition of ovarian abnormalities followed with serial transvaginal ultrasonography." Obstetrics and gynecology 122, 2 Pt 1 (2013): 210-7. [PubMed Link] |[Full Text] 

     

    17. Baldwin, L.;Huang, B.; Miller, R.W.;Tucker, T.; Goodrich, S.T.; Podzielinski, I. ;Desimone, C.P.;Ueland, F.R.;Van Nagell, J.R.;Seamon, L.G. "Ten-year relative survival for epithelial ovarian cancer." Obstetrics and gynecology 120, 3 (2012): 612-8. [PubMed Link] | [Full Text] 

     

    18. Skaggs, H.S.;Saunders, B.A.; Miller, R.W.; Goodrich, S.T.;King, M.S.;Kimbler, K.D.;Branscum, A.J.;Fung, E.T.;DePriest, P.D.;Van Nagell, J.R.;Ueland, F.R.;Baron, A.T. "Ovarian cyst fluids are a cache of tumor biomarkers that include calgranulin A and calgranulin B isoforms." Cancer investigation 31, 7 (2013):433-53. [PubMed Link] | [Full Text] 

Scott Goodrich, M.D

  1. McDonald JM, Doran S, DeSimone CP, Ueland FR, DePriest PD, Ware RA, Saunders BA, Pavlik EJ, Goodrich S, Kryscio RJ, van Nagell JR Jr.Predicting risk of malignancy in adnexal masses. Obstet Gynecol. 2010 Apr;115(4):687-94.PMID: 20308826 [PubMed - in process].
  2. Ware, R., Smith, A., DeSimone, C, Seamon, L., Goodrich, S., Podzielinski, I. , Van Nagel!, J., Zhang, Z., Ueland, F.  A  multi-institutional evaluation of ACOG and SGO referral guidelines for an ovarian massSociety of Gynecologic Oncology 2010 Abstract #27.
  3. Saunders, B, Podzielinski, I, Ware, R, Goodrich, S, DeSimone, C, Ueland, F, ,DePriest, P, Pavlik, E, Seamon, L, Van Nagell, J. Risk of malignancy in sonographically confirmed septated cystic ovarian tumors.  Society of Gynecologic Oncology 2010 Abstract #53.
  4. Ueland, F, DeSimone, C, Seamon, L, Ware, R, Goodrich, S, Podzielinski, I, Smith, A, Santoso, J,. Van Nagell, J, Zhang, Z. The OVA1 test improves the preoperative assessment of ovarian tumors . Society of Gynecologic Oncology 2010 Abstract #54.
  5. Risk of malignancy in sonographically confirmed septated cystic ovarian tumors.  

     

    6. Saunders BA, Podzielinski I, Ware RA, Goodrich S, DeSimone CP, Ueland FR, Seamon L, Ubellacker J, Pavlik EJ, Kryscio RJ, van Nagell JR Jr. Risk of malignancy in sonographically confirmed septated cystic ovarian tumors. Gynecol Oncol. 2010 Sep;118(3):278-82. Epub 2010 Jun 15. [PubMed Link] | [Full Text] 

     

    7,  Ware Miller R, Smith A, DeSimone CP, Seamon L, Goodrich S, Podzielinski I, Sokoll L, van Nagell JR Jr, Zhang Z, Ueland FR. Performance of the American College of Obstetricians and Gynecologists' ovarian tumor referral guidelines with a multivariate index assayObstet Gynecol. 2011 Jun;117(6):1298-306.[PubMed Link] | [Full Text] 

     

    8.  Baldwin, L.;Huang, B.; Miller, R.W.;Tucker, T.; Goodrich, S.T.; Podzielinski, I. ;Desimone, C.P.;Ueland, F.R.;Van Nagell, J.R.;Seamon, L.G. "Ten-year relative survival for epithelial ovarian cancer." Obstetrics and gynecology gynecology 120, 3 (2012): 612-8. [PubMed Link] | [Full Text]

     

    9.  Nagell JR, J.; Miller, R.W.;Desimone, C.P.;Ueland, F.R.; Podzielinski, I.; Goodrich, S.T.;Elder, J.W.;Huang, B.;Kryscio, R.J.;Pavlik, E.J. "Long-term survival of women with epithelial ovarian cancer detected by ultrasonographic screening." Obstetrics and gynecology 118, 6 (2011): 1212-21. [PubMed Link] | [Full Text] 

     

    10.  Ueland, F.R.;Desimone, C.P.;Seamon, L.G.; Miller, R.W.; Goodrich, S.T.; Podzielinski, I.;Sokoll, L.;Smith, A.;Nagell JR, J.;Zhang, Z. "Effectiveness of a multivariate index assay in the preoperative assessment of ovarian tumors." Obstetrics and gynecology 117, 6 (2011): 1289-97. [PubMed Link] | [Full Text]  

     

    11.  Goodrich, S.T.;Bristow, R.E.;Santoso, J.T.;Miller, R.W.;Smith, A.;Zhang, Z.;Ueland, F.R. "The Effect of Ovarian Imaging on the Clinical Interpretation of a Multivariate Index Assay." American journal of obstetrics and gynecology (2014): [PubMed Link] | [Full Text] 

     

    12.  Skaggs, H.S.;Saunders, B.A.; Miller, R.W.; Goodrich, S.T.;King, M.S.;Kimbler, K.D.;Branscum, A.J.;Fung, E.T.;DePriest, P.D.;Van Nagell, J.R.;Ueland, F.R.;Baron, A.T. "Ovarian cyst fluids are a cache of tumor biomarkers that include calgranulin A and calgranulin B isoforms." Cancer investigation 31, 7 (2013):433-53. [PubMed Link] | [Full Text] 

Iwona Podzielinski, M.D

  1. Ware, R., Smith, A., DeSimone, C, Seamon, L., Goodrich, S., Podzielinski, I. , Van Nagel!, J., Zhang, Z., Ueland, F.  A  multi-institutional evaluation of ACOG and SGO referral guidelines for an ovarian massSociety of Gynecologic Oncology 2010 Abstract #27.
  2. Saunders, B, Podzielinski, I, Ware, R, , Goodrich, S, DeSimone, C, Ueland, F, ,DePriest, P, Pavlik, E, Seamon, L, Van Nagell, J. Risk of malignancy in sonographically confirmed septated cystic ovarian tumors.  Society of Gynecologic Oncology 2010 Abstract #53.
  3. Ueland, F, DeSimone, C, Seamon, L, Ware, R, Goodrich, S, Podzielinski, I, Smith, A, Santoso, J,. Van Nagell, J, Zhang, Z. The OVA1 test improves the preoperative assessment of ovarian tumors . Society of Gynecologic Oncology 2010 Abstract #54.
  4. Podzielinski, I, Quick, A, DeSimone,C, Chino, J, Escobar, P,,
    Cohn, C, Lopez, M, Alvarez-Secord, A, Havrilesky, L, Seamon, L. Primary radiation therapy for medically inoperable patients with clinical stage I and II endometrial cancer . Society of Gynecologic Oncology 2010 Abstract #211.  
  5. Ware, R, Pavlik, Doran, S, Darag, W, Reynolds, S,. Ueland, F, DeSimone, C, Podzielinski, I, Van Nagell, J. Prevalence, size and duration of ovarian abnormalities detected on transvaginal sonography Society of Gynecologic Oncology 2010 Abstract #266.
  6. Risk of malignancy in sonographically confirmed septated cystic ovarian tumors.  Saunders BA, Podzielinski I, Ware RA, Goodrich S, DeSimone CP, Ueland FR, Seamon L, Ubellacker J, Pavlik EJ, Kryscio RJ, van Nagell JR Jr.

    Gynecol Oncol. 2010 Sep;118(3):278-82. Epub 2010 Jun 15. [PubMed Link] | [Full Text] 

    7. Baldwin, L.;Huang, B.; Miller, R.W.;Tucker, T.; Goodrich, S.T.; Podzielinski, I. ;Desimone, C.P.;Ueland, F.R.;Van Nagell, J.R.;Seamon, L.G. "Ten-year relative survival for epithelial ovarian cancer." Obstetrics and gynecology 120, 3 (2012): 612-8. [PubMed Link] | [Full Text]

     

    8. Nagell JR, J.; Miller, R.W.;Desimone, C.P.;Ueland, F.R.; Podzielinski, I.; Goodrich, S.T.;Elder, J.W.;Huang, B.;Kryscio, R.J.;Pavlik, E.J. "Long-term survival of women with epithelial ovarian cancer detected by ultrasonographic screening." Obstetrics and gynecology 118, 6 (2011): 1212-21. [PubMed Link] | [Full Text] 

     

    9. Podzielinski, I. ; Saunders, B.A.;Kimbler, K.D.;Branscum, A.J.;Fung, E.T.;DePriest, P.D.;Van Nagell, J.R.;Ueland, F.R.;Baron, A.T. "Apolipoprotein concentrations are elevated in malignant ovarian cyst fluids suggesting that lipoprotein metabolism is dysregulated in epithelial ovarian cancer." Cancer investigation 31, 4 (2013): 258-72. [PubMed Link] | [Full Text] 

     

    10. Ueland, F.R.;Desimone, C.P.;Seamon, L.G.; Miller, R.W.; Goodrich, S.T.; Podzielinski, I.;Sokoll, L.;Smith, A.;Nagell JR, J.;Zhang, Z. "Effectiveness of a multivariate index assay in the preoperative assessment of ovarian tumors." Obstetrics and gynecology 117, 6 (2011): 1289-97. [PubMed Link] | [Full Text]  

     

    11. Ware Miller, R.;Smith, A.;Desimone, C.P.;Seamon, L.; Goodrich, S.T.; Podzielinski, I.;Sokoll, L.;Nagell JR, J.;Zhang, Z.;Ueland, F.R. "Performance of the American College of Obstetricians and Gynecologists' ovarian tumor referral guidelines with a multivariate index assay." Obstetrics and gynecology 117, 6(2011): 1298-306. [PubMed Link] | [Full Text] 

     

    12.  Seamon, L.G.;Tarrant, R.L.;Fleming, S.T.;Vanderpool, R.C.;Pachtman, S.; Podzielinski, I.;Branscum, A.J.;Feddock, J.M.;Randall, M.E.;Desimone, C.P. "Cervical cancer survival for patients referred to a tertiary care center in Kentucky ." Gynecologic oncology 123, 3 (2011): 565-70. [PubMed Link] | [Full Text] 

     

     


    Jeffrey Elder, M.D

     

    1. Pavlik, E.J.;Ueland, F.R.; Miller, R.W.;Ubellacker, J.M.;Desimone, C.P.; Elder, J.; Hoff, J.; Baldwin, L.;Kryscio, R.J.;Nagell JR, J. "Frequency and disposition of ovarian abnormalities followed with serial transvaginal ultrasonography." Obstetrics and gynecology 122, 2 Pt 1 (2013): 210-7. [PubMed Link] |[Full Text] 

     

    2. DeSimone, C.P.;Elder, J.;Nagell JR, J. "Selective inguinal lymphadenectomy in the treatment of invasive squamous cell carcinoma of the vulva." International journal of surgical oncology 2011, (2014):284374. [PubMed Link] | [Full Text] 

     

    3. Nagell JR, J.; Miller, R.W.;Desimone, C.P.;Ueland, F.R.; Podzielinski, I.; Goodrich, S.T.;Elder, J.W.;Huang, B.;Kryscio, R.J.;Pavlik, E.J. "Long-term survival of women with epithelial ovarian cancer detected by ultrasonographic screening." Obstetrics and gynecology 118, 6 (2011): 1212-21. [PubMed Link] | [Full Text] 

     

    John Hoff, M.D


    1. Pavlik, E.J.;Hoff, J.;Woolum, D.;Liang, Y.;Wijers, C.;Schwartz, M.; Lefringhouse, J.;Baldwin, L. "Metrics of the gynecologic oncology literature focused on cited utilization and costs." Gynecologic oncology 132,2 (2014): 423-7. [PubMed Link] | [Full Text]

     

    2. Pavlik, E.J.;Ueland, F.R.; Miller, R.W.;Ubellacker, J.M.;Desimone, C.P.; Elder, J.; Hoff, J.; Baldwin, L.;Kryscio, R.J.;Nagell JR, J. "Frequency and disposition of ovarian abnormalities followed with serial transvaginal ultrasonography." Obstetrics and gynecology 122, 2 Pt 1 (2013): 210-7. [PubMed Link] |[Full Text]

     

    3. Nagell JR, J.; Hoff, J. "Transvaginal ultrasonography in ovarian cancer screening: current perspectives." International journal of women's health 6, (2014): 25-33. [PubMed Link] | [Full Text]  

     


    Lauren Baldwin, M.D


    1.  Pavlik, E.J.;Hoff, J.;Woolum, D.;Liang, Y.;Wijers, C.;Schwartz, M.; Lefringhouse, J.;Baldwin, L. "Metrics of the gynecologic oncology literature focused on cited utilization and costs." Gynecologic oncology 132,2 (2014): 423-7. [PubMed Link] | [Full Text]

     

    2.  Feddock, J.;Randall, M.;Kudrimoti, M.; Baldwin, L.;Shah, P.;Weiss, H.;Simone, C. "Impact of post-radiation biopsies on development of fistulae in patients with cervical cancer." Gynecologic oncology(2014): [PubMed Link] | [Full Text] 

     

    3. Pavlik, E.J.;Ueland, F.R.; Miller, R.W.;Ubellacker, J.M.;Desimone, C.P.; Elder, J.; Hoff, J.; Baldwin, L.;Kryscio, R.J.;Nagell JR, J. "Frequency and disposition of ovarian abnormalities followed with serial transvaginal ultrasonography." Obstetrics and gynecology 122, 2 Pt 1 (2013): 210-7. [PubMed Link] |[Full Text]

     

    4. Baldwin, L.;Huang, B.; Miller, R.W.;Tucker, T.; Goodrich, S.T.; Podzielinski, I. ;Desimone, C.P.;Ueland, F.R.;Van Nagell, J.R.;Seamon, L.G. "Ten-year relative survival for epithelial ovarian cancer." Obstetrics and gynecology 120, 3 (2012): 612-8. [PubMed Link] | [Full Text]  


    Jason Lefringhouse, M.D.


    1. Pavlik, E.J.;Hoff, J.;Woolum, D.;Liang, Y.;Wijers, C.;Schwartz, M.; Lefringhouse, J.;Baldwin, L. "Metrics of the gynecologic oncology literature focused on cited utilization and costs." Gynecologic oncology 132,2 (2014): 423-7. [PubMed Link] | [Full Text]

     


                 

 

 

Back to Top

VISITORS

SCHOOLS

Bluegrass Photo gallery
Gynecological Cancers
Cervical Cancer
Endometrial Cancer
Ovarian Cancer
Uterine Cancer
Vaginal Cancer
Vulvar Cancer
Breast Cancer
<more>...
   
UK Ovarian Cancer Screening
UK-pioneered Ovarian Cancer Screening
 Pap Smear Info
<more>...
   
General Health Info
Gynecologic Health
Clinical Trials
  GOG
  NCI
  CancerTrialsHelp

Comments to Ed Pavlik, Phone: (859) 323-3830,  Fax: (859) 323-1018, (epaul1@uky.edu)

Copyright © 2011-2014, University of Kentucky Chandler Medical Center
Terms, Conditions & Privacy Statement
An Equal Opportunity University

.